Literature DB >> 12516198

Anemia and the liver. Hepatobiliary manifestations of anemia.

Corwin Q Edwards1.   

Abstract

Many types of hemolytic anemia may be associated with liver disease. Liver injury can be caused by the adherence of deformed or hemolyzed erythrocyses to hepatic vascular endothelium. Adhesion of large numbers of hemolyzed red blood cells to hepatic macrophages, or occlusion of hepatic sinusoids by fragmented red cells, can also result in injury of the liver. Thrombosis of the hepatic or portal vein is associated with some types of hemolytic anemia, and can cause severe liner injury. These are some examples of hepatic injury that can be caused by hemolytic anemias. This article discusses some aspects of liver disease that is associated with sickle cell anemia, paroxysmal nocturnal hemoglobinuria, glucose-6-phosphate dehydrogenase deficiency, hereditary spherocytosis, and HELLP syndrome.

Entities:  

Mesh:

Year:  2002        PMID: 12516198     DOI: 10.1016/s1089-3261(02)00050-8

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  7 in total

1.  HELLP syndrome complicated bile duct injury and subsequent left hepatic lobe atrophy.

Authors:  Ayse L Mindikoglu; Shilun D Li; Sherri L Yong; Marc A Borge; John Brems; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

Review 2.  Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.

Authors:  Ali R Elyassi; Henry H Rowshan
Journal:  Anesth Prog       Date:  2009

3.  Caring for Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient Patients: Implications for Pharmacy.

Authors:  Jeff Bubp; Marilyn Jen; Karl Matuszewski
Journal:  P T       Date:  2015-09

4.  Splenic infarction in a patient hereditary spherocytosis, protein C deficiency and acute infectious mononucleosis.

Authors:  Christian Breuer; Gisela Janssen; Hans-Jürgen Laws; Jörg Schaper; Ertan Mayatepek; Horst Schroten; Tobias Tenenbaum
Journal:  Eur J Pediatr       Date:  2008-07-05       Impact factor: 3.183

5.  Acute fulminant cholestatic jaundice in sickle cell disease.

Authors:  Ahmad M Al-Suleiman; Jawad Bu-sobaih
Journal:  Ann Saudi Med       Date:  2006 Mar-Apr       Impact factor: 1.526

6.  Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies.

Authors:  Olalekan A Uthman; Rachel Saunders; David Sinclair; Patricia Graves; Hellen Gelband; Aileen Clarke; Paul Garner
Journal:  BMJ Open       Date:  2014-05-14       Impact factor: 2.692

Review 7.  Hepatobiliary Manifestations of Sickle Cell Anemia.

Authors:  Hussain Issa; Ahmed H Al-Salem
Journal:  Gastroenterology Res       Date:  2010-01-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.